This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lilley, C. E.
Right arrow Articles by Coffin, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lilley, C. E.
Right arrow Articles by Coffin, R. S.

 Previous Article  |  Next Article 

Journal of Virology, May 2001, p. 4343-4356, Vol. 75, No. 9
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.9.4343-4356.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Multiple Immediate-Early Gene-Deficient Herpes Simplex Virus Vectors Allowing Efficient Gene Delivery to Neurons in Culture and Widespread Gene Delivery to the Central Nervous System In Vivo

Caroline E. Lilley,1 Filitsa Groutsi,1 ZiQun Han,2 James A. Palmer,1,2 Patrick N. Anderson,3 David S. Latchman,4 and Robert S. Coffin1,2,*

Department of Molecular Pathology,1 Department of Anatomy and Developmental Biology,3 and Institute of Child Health,4 University College London, and Biovex, Ltd.,2 London, England

Received 5 December 2000/Accepted 5 February 2001

Herpes simplex virus (HSV) has several potential advantages as a vector for delivering genes to the nervous system. The virus naturally infects and remains latent in neurons and has evolved the ability of highly efficient retrograde transport from the site of infection at the periphery to the site of latency in the spinal ganglia. HSV is a large virus, potentially allowing the insertion of multiple or very large transgenes. Furthermore, HSV does not integrate into the host chromosome, removing any potential for insertional activation or inactivation of cellular genes. However, the development of HSV vectors for the central nervous system that exploit these properties has been problematical. This has mainly been due to either vector toxicity or an inability to maintain transgene expression. Here we report the development of highly disabled versions of HSV-1 deleted for ICP27, ICP4, and ICP34.5/open reading frame P and with an inactivating mutation in VP16. These viruses express only minimal levels of any of the immediate-early genes in noncomplementing cells. Transgene expression is maintained for extended periods with promoter systems containing elements from the HSV latency-associated transcript promoter (J. A. Palmer et al., J. Virol. 74:5604-5618, 2000). Unlike less-disabled viruses, these vectors allow highly effective gene delivery both to neurons in culture and to the central nervous system in vivo. Gene delivery in vivo is further enhanced by the retrograde transport capabilities of HSV. Here the vector is efficiently transported from the site of inoculation to connected sites within the nervous system. This is demonstrated by gene delivery to both the striatum and substantia nigra following striatal inoculation; to the spinal cord, spinal ganglia, and brainstem following injection into the spinal cord; and to retinal ganglion neurons following injection into the superior colliculus and thalamus.

* Corresponding author. Mailing address: Department of Molecular Pathology, The Windeyer Institute of Medical Sciences, University College London, 46 Cleveland St., London W1P 6DB, England. Phone: 44-020-7504-9230. Fax: 44-020-7813-1015. E-mail: r.coffin{at}ucl.ac.uk.

Journal of Virology, May 2001, p. 4343-4356, Vol. 75, No. 9
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.9.4343-4356.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Anesti, A.-M., Peeters, P. J., Royaux, I., Coffin, R. S. (2008). Efficient delivery of RNA Interference to peripheral neurons in vivo using herpes simplex virus. Nucleic Acids Res 36: e86-e86 [Abstract] [Full Text]  
  • Kummer, M., Turza, N. M., Muhl-Zurbes, P., Lechmann, M., Boutell, C., Coffin, R. S., Everett, R. D., Steinkasserer, A., Prechtel, A. T. (2007). Herpes Simplex Virus Type 1 Induces CD83 Degradation in Mature Dendritic Cells with Immediate-Early Kinetics via the Cellular Proteasome. J. Virol. 81: 6326-6338 [Abstract] [Full Text]  
  • Leclere, P. G., Norman, E., Groutsi, F., Coffin, R., Mayer, U., Pizzey, J., Tonge, D. (2007). Impaired Axonal Regeneration by Isolectin B4-Binding Dorsal Root Ganglion Neurons In Vitro. J. Neurosci. 27: 1190-1199 [Abstract] [Full Text]  
  • Prechtel, A. T., Turza, N. M., Kobelt, D. J., Eisemann, J. I., Coffin, R. S., McGrath, Y., Hacker, C., Ju, X., Zenke, M., Steinkasserer, A. (2005). Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. J. Gen. Virol. 86: 1645-1657 [Abstract] [Full Text]  
  • Lilley, C. E., Carson, C. T., Muotri, A. R., Gage, F. H., Weitzman, M. D. (2005). DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 102: 5844-5849 [Abstract] [Full Text]  
  • Boutell, C., Everett, R. D. (2004). Herpes Simplex Virus Type 1 Infection Induces the Stabilization of p53 in a USP7- and ATM-Independent Manner. J. Virol. 78: 8068-8077 [Abstract] [Full Text]  
  • Everett, R. D., Sourvinos, G., Leiper, C., Clements, J. B., Orr, A. (2004). Formation of Nuclear Foci of the Herpes Simplex Virus Type 1 Regulatory Protein ICP4 at Early Times of Infection: Localization, Dynamics, Recruitment of ICP27, and Evidence for the De Novo Induction of ND10-Like Complexes. J. Virol. 78: 1903-1917 [Abstract] [Full Text]  
  • Samady, L., Costigliola, E., MacCormac, L., McGrath, Y., Cleverley, S., Lilley, C. E., Smith, J., Latchman, D. S., Chain, B., Coffin, R. S. (2003). Deletion of the Virion Host Shutoff Protein (vhs) from Herpes Simplex Virus (HSV) Relieves the Viral Block to Dendritic Cell Activation: Potential of vhs- HSV Vectors for Dendritic Cell-Mediated Immunotherapy. J. Virol. 77: 3768-3776 [Abstract] [Full Text]  
  • Thomas, S. K., Lilley, C. E., Latchman, D. S., Coffin, R. S. (2002). A Protein Encoded by the Herpes Simplex Virus (HSV) Type 1 2-Kilobase Latency-Associated Transcript Is Phosphorylated, Localized to the Nucleus, and Overcomes the Repression of Expression from Exogenous Promoters When Inserted into the Quiescent HSV Genome. J. Virol. 76: 4056-4067 [Abstract] [Full Text]  
  • Perkins, D., Pereira, E. F. R., Gober, M., Yarowsky, P. J., Aurelian, L. (2002). The Herpes Simplex Virus Type 2 R1 Protein Kinase (ICP10 PK) Blocks Apoptosis in Hippocampal Neurons, Involving Activation of the MEK/MAPK Survival Pathway. J. Virol. 76: 1435-1449 [Abstract] [Full Text]  
  • Mazarakis, N. D., Azzouz, M., Rohll, J. B., Ellard, F. M., Wilkes, F. J., Olsen, A. L., Carter, E. E., Barber, R. D., Baban, D. F., Kingsman, S. M., Kingsman, A. J., O'Malley, K., Mitrophanous, K. A. (2001). Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 10: 2109-2121 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»